NUSAP1 influences the DNA damage response by controlling BRCA1 protein levels

Cancer Biology and Therapy

Volumn 15, Issue 5, 2014, Pages 533-543

  Kotian, Shweta ^a   Banerjee, Tapahsama ^a   Lockhart, Ainsley ^a   Huang, Kun ^a   Catalyurek, Umit V ^a   Parvin, Jeffrey D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

BRCA1; Centrosomes; DNA repair; Homologous recombination; NUSAP1

Indexed keywords

BRCA1 PROTEIN; NUCLEAR PROTEIN; NUCLEOLAR SPINDLE ASSOCIATED PROTEIN 1; UNCLASSIFIED DRUG; MICROTUBULE ASSOCIATED PROTEIN; NUSAP PROTEIN, HUMAN; SINGLE STRANDED DNA;

ARTICLE; BREAST CANCER; CARCINOGENESIS; CELL CYCLE G2 PHASE; CENTROSOME; DNA REPAIR; DOUBLE STRANDED DNA BREAK; FEMALE; GENE DUPLICATION; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; PHENOTYPE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; DNA DAMAGE; G2 PHASE CELL CYCLE CHECKPOINT; GENETICS; METABOLISM; RADIATION RESPONSE; S PHASE CELL CYCLE CHECKPOINT; TUMOR CELL LINE;

BRCA1 PROTEIN; CELL LINE, TUMOR; CENTROSOME; DNA DAMAGE; DNA REPAIR; DNA, SINGLE-STRANDED; G2 PHASE CELL CYCLE CHECKPOINTS; HOMOLOGOUS RECOMBINATION; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; S PHASE CELL CYCLE CHECKPOINTS;

EID: 84899827080     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.28019     Document Type: Article

References (56)

1. Huen MS, Sy SM, Chen J. BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Biol 2010; 11:138-48; PMID:20029420; http://dx.doi.org/10.1038/nrm2831
2. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266:66-71; PMID:7545954; http://dx.doi.org/10.1126/science.7545954 (Pubitemid 24345325)
3. Xu B, O'Donnell AH, Kim ST, Kastan MB. Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation. Cancer Res 2002; 62:4588-91; PMID:12183412
4. Kim H, Huang J, Chen J. CCDC98 is a BRCA1- BRCT domain-binding protein involved in the DNA damage response. Nat Struct Mol Biol 2007; 14:710-5; PMID:17643122; http://dx.doi.org/10.1038/nsmb1277 (Pubitemid 47220062)
5. Starita LM, Parvin JD. The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair. Curr Opin Cell Biol 2003; 15:345-50; PMID:12787778; http://dx.doi.org/10.1016/S0955-0674(03)00042-5 (Pubitemid 36638654)
6. Wang B, Matsuoka S, Ballif BA, Zhang D, Smogorzewska A, Gygi SP, Elledge SJ. Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science 2007; 316:1194-8; PMID:17525340; http://dx.doi.org/10.1126/ science.1139476 (Pubitemid 46877482)
7. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 2000; 10:886-95; PMID:10959836; http://dx.doi.org/10.1016/S0960-9822(00)00610-2 (Pubitemid 30647617)
8. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 1997; 88:265-75; PMID:9008167; http://dx.doi.org/10.1016/S0092-8674(00) 81847-4 (Pubitemid 28015875)
9. Moynahan ME, Chiu JW, Koller BH, Jasin M. Brca1 controls homology-directed DNA repair. Mol Cell 1999; 4:511-8; PMID:10549283; http://dx.doi.org/10.1016/S1097-2765(00)80202-6 (Pubitemid 29531131)
10. Snouwaert JN, Gowen LC, Latour AM, Mohn AR, Xiao A, DiBiase L, Koller BH. BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene. Oncogene 1999; 18:7900-7; PMID:10630642; http://dx.doi.org/10.1038/sj.onc.1203334 (Pubitemid 30066235)
11. Stark JM, Pierce AJ, Oh J, Pastink A, Jasin M. Genetic steps of mammalian homologous repair with distinct mutagenic consequences. Mol Cell Biol 2004; 24:9305-16; PMID:15485900; http://dx.doi.org/10.1128/MCB.24.21.9305-9316.2004 (Pubitemid 39391669)
12. Zhong Q, Boyer TG, Chen PL, Lee WH. Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts. Cancer Res 2002; 62:3966-70; PMID:12124328 (Pubitemid 34791061)
13. Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell 2007; 28:739-45; PMID:18082599; http://dx.doi.org/10.1016/j.molcel.2007.11.015 (Pubitemid 350217064)
14. Huen MS, Chen J. The DNA damage response pathways: at the crossroad of protein modifications. Cell Res 2008; 18:8-16; PMID:18087291; http://dx.doi.org/10.1038/cr.2007.109
15. Raemaekers T, Ribbeck K, Beaudouin J, Annaert W, Van Camp M, Stockmans I, Smets N, Bouillon R, Ellenberg J, Carmeliet G. NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization. J Cell Biol 2003; 162:1017-29; PMID:12963707; http://dx.doi.org/10.1083/jcb.200302129 (Pubitemid 37174185)
16. Vanden Bosch A, Raemaekers T, Denayer S, Torrekens S, Smets N, Moermans K, Dewerchin M, Carmeliet P, Carmeliet G. NuSAP is essential for chromatininduced spindle formation during early embryogenesis. J Cell Sci 2010; 123:3244-55; PMID:20807801; http://dx.doi.org/10.1242/jcs.063875
17. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007; 316:1160-6; PMID:17525332; http://dx.doi.org/10.1126/science.1140321 (Pubitemid 46877472)
18. Xie P, Li L, Xing G, Tian C, Yin Y, He F, Zhang L. ATM-mediated NuSAP phosphorylation induces mitotic arrest. Biochem Biophys Res Commun 2011; 404:413-8; PMID:21130744; http://dx.doi.org/10.1016/j.bbrc.2010.11.135
19. Emanuele MJ, Elia AE, Xu Q, Thoma CR, Izhar L, Leng Y, Guo A, Chen YN, Rush J, Hsu PW, et al. Global identification of modular cullin-RING ligase substrates. Cell 2011; 147:459-74; PMID:21963094; http://dx.doi.org/10.1016/j. cell.2011.09.019
20. Bogunovic D, O'Neill DW, Belitskaya-Levy I, Vacic V, Yu YL, Adams S, Darvishian F, Berman R, Shapiro R, Pavlick AC, et al. Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proc Natl Acad Sci U S A 2009; 106:20429-34; PMID:19915147; http://dx.doi.org/10.1073/pnas.0905139106
21. Gulzar ZG, McKenney JK, Brooks JD. Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1. Oncogene 2013; 32:70-7; PMID:22349817; http://dx.doi.org/10.1038/onc.2012.27
22. Marie SK, Okamoto OK, Uno M, Hasegawa AP, Oba-Shinjo SM, Cohen T, Camargo AA, Kosoy A, Carlotti CG Jr., Toledo S, et al. Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas. Int J Cancer 2008; 122:807-15; PMID:17960622; http://dx.doi.org/ 10.1002/ijc.23189
23. Ryu B, Kim DS, Deluca AM, Alani RM. Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS One 2007; 2:e594; PMID:17611626; http://dx.doi.org/10.1371/journal.pone.0000594
24. Satow R, Shitashige M, Kanai Y, Takeshita F, Ojima H, Jigami T, Honda K, Kosuge T, Ochiya T, Hirohashi S, et al. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma. Clin Cancer Res 2010; 16:2518-28; PMID:20388846; http://dx.doi.org/10.1158/1078-0432.CCR-09-2214
25. Wadia PP, Coram M, Armstrong RJ, Mindrinos M, Butte AJ, Miklos DB. Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation. Blood 2010; 115:2077-87; PMID:20053754; http://dx.doi.org/10. 1182/blood-2009-03-211375
26. Chen DT, Nasir A, Culhane A, Venkataramu C, Fulp W, Rubio R, Wang T, Agrawal D, McCarthy SM, Gruidl M, et al. Proliferative genes dominate malignancy- risk gene signature in histologically-normal breast tissue. Breast Cancer Res Treat 2010; 119:335-46; PMID:19266279; http://dx.doi.org/10.1007/ s10549-009-0344-y
27. Kokkinakis DM, Liu X, Neuner RD. Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma. Mol Cancer Ther 2005; 4:1338-48; PMID:16170025; http://dx.doi.org/10.1158/1535-7163.MCT-05- 0141
28. Lauss M, Kriegner A, Vierlinger K, Visne I, Yildiz A, Dilaveroglu E, Noehammer C. Consensus genes of the literature to predict breast cancer recurrence. Breast Cancer Res Treat 2008; 110:235-44; PMID:17899371; http://dx.doi.org/10.1007/s10549-007-9716-3 (Pubitemid 351793872)
29. Stuart JE, Lusis EA, Scheck AC, Coons SW, Lal A, Perry A, Gutmann DH. Identification of gene markers associated with aggressive meningioma by filtering across multiple sets of gene expression arrays. J Neuropathol Exp Neurol 2011; 70:1-12; PMID:21157382; http://dx.doi.org/10.1097/NEN. 0b013e3182018f1c
30. Kretschmer C, Sterner-Kock A, Siedentopf F, Schoenegg W, Schlag PM, Kemmner W. Identification of early molecular markers for breast cancer. Mol Cancer 2011; 10:15; PMID:21314937; http://dx.doi.org/10.1186/1476-4598-10-15
31. Cario G, Fetz A, Bretscher C, Möricke A, Schrauder A, Stanulla M, Schrappe M. Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia. Ann Hematol 2008; 87:709-16; PMID:18521602; http://dx.doi.org/10.1007/s00277-008-0504-x
32. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, Dennis J, Wang Q, Humphreys MK, Luccarini C, et al.; Netherlands Collaborative Group on Hereditary Breast and Ovarian Cancer (HEBON); Familial Breast Cancer Study (FBCS); Gene Environment Interaction of Breast Cancer in Germany (GENICA) Network; kConFab Investigators; Australian Ovarian Cancer Study Group. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 2012; 44:312-8; PMID:22267197; http://dx.doi.org/10.1038/ng.1049
33. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J, Bojesen SE, Bolla MK, et al.; Breast and Ovarian Cancer Susceptibility Collaboration; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON); kConFab Investigators; Australian Ovarian Cancer Study Group; GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013; 45:353-61, e1-2; PMID:23535729; http://dx.doi.org/10.1038/ng.2563
34. Pujana MA, Han JD, Starita LM, Stevens KN, Tewari M, Ahn JS, Rennert G, Moreno V, Kirchhoff T, Gold B, et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet 2007; 39:1338-49; PMID:17922014; http://dx.doi.org/10.1038/ng.2007.2 (Pubitemid 350035000)
35. Zhang J, Lu K, Xiang Y, Islam M, Kotian S, Kais Z, Lee C, Arora M, Liu HW, Parvin JD, et al. Weighted frequent gene co-expression network mining to identify genes involved in genome stability. PLoS Comput Biol 2012; 8:e1002656; PMID:22956898; http://dx.doi.org/10.1371/journal.pcbi.1002656
36. Kais Z, Barsky SH, Mathsyaraja H, Zha A, Ransburgh DJ, He G, Pilarski RT, Shapiro CL, Huang K, Parvin JD. KIAA0101 interacts with BRCA1 and regulates centrosome number. Mol Cancer Res 2011; 9:1091-9; PMID:21673012; http://dx.doi.org/10.1158/1541-7786.MCR-10-0503
37. Bozdag D, Parvin JD, Catalyurek UV. A Biclustering Method to Discover Co-regulated Genes Using Diverse Gene Expression Datasets. Proceedings of First International Conference on Bioinformatics and Computational Biology (BICoB), LNCS 2009; 5462:151-63.
38. Eren K, Deveci M, Küçüktunç O, Çatalyürek UV. A comparative analysis of biclustering algorithms for gene expression data. Brief Bioinform 2013; 14:279-92; PMID:22772837; http://dx.doi.org/10.1093/bib/bbs032
39. Pierce AJ, Johnson RD, Thompson LH, Jasin M. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev 1999; 13:2633-8; PMID:10541549; http://dx.doi.org/10.1101/gad.13.20.2633 (Pubitemid 29508550)
40. Ransburgh DJ, Chiba N, Ishioka C, Toland AE, Parvin JD. Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination. Cancer Res 2010; 70:988-95; PMID:20103620; http://dx.doi.org/10. 1158/0008-5472.CAN-09-2850
41. Bennardo N, Cheng A, Huang N, Stark JM. Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet 2008; 4:e1000110; PMID:18584027; http://dx.doi.org/10.1371/journal.pgen. 1000110
42. Towler WI, Zhang J, Ransburgh DJ, Toland AE, Ishioka C, Chiba N, Parvin JD. Analysis of BRCA1 variants in double-strand break repair by homologous recombination and single-strand annealing. Hum Mutat 2013; 34:439-45; PMID:23161852; http://dx.doi.org/10.1002/humu.22251
43. Starita LM, Machida Y, Sankaran S, Elias JE, Griffin K, Schlegel BP, Gygi SP, Parvin JD. BRCA1- dependent ubiquitination of gamma-tubulin regulates centrosome number. Mol Cell Biol 2004; 24:8457-66; PMID:15367667; http://dx.doi.org/10.1128/MCB.24.19.8457-8466.2004 (Pubitemid 39245068)
44. Kais Z, Chiba N, Ishioka C, Parvin JD. Functional differences among BRCA1 missense mutations in the control of centrosome duplication. Oncogene 2012; 31:799-804; PMID:21725363; http://dx.doi.org/10.1038/onc.2011.271
45. Sankaran S, Starita LM, Groen AC, Ko MJ, Parvin JD. Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination. Mol Cell Biol 2005; 25:8656-68; PMID:16166645; http://dx.doi.org/10.1128/MCB.25. 19.8656-8668.2005 (Pubitemid 41369184)
46. Lingle WL, Salisbury JL. Methods for the analysis of centrosome reproduction in cancer cells. Methods Cell Biol 2001; 67:325-36; PMID:11550478; http://dx.doi.org/10.1016/S0091-679X(01)67022-5
47. D'Assoro AB, Stivala F, Barrett S, Ferrigno G, Salisbury JL. GFP-centrin as a marker for centriole dynamics in the human breast cancer cell line MCF-7. Ital J Anat Embryol 2001; 106(Suppl 1):103-10; PMID:11729945
48. Ruffner H, Verma IM. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc Natl Acad Sci U S A 1997; 94:7138-43; PMID:9207057; http://dx.doi.org/10.1073/pnas.94.14.7138 (Pubitemid 27345281)
49. Choudhury AD, Xu H, Baer R. Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression. J Biol Chem 2004; 279:33909-18; PMID:15166217; http://dx.doi.org/10.1074/jbc.M403646200 (Pubitemid 39063041)
50. Jin Y, Xu XL, Yang MC, Wei F, Ayi TC, Bowcock AM, Baer R. Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proc Natl Acad Sci U S A 1997; 94:12075-80; PMID:9342365; http://dx.doi.org/10.1073/pnas.94.22.12075 (Pubitemid 27467845)
51. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273:5858-68; PMID:9488723; http://dx.doi.org/10.1074/jbc.273.10.5858 (Pubitemid 28124064)
52. Bhattacharyya A, Ear US, Koller BH, Weichselbaum RR, Bishop DK. The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem 2000; 275:23899-903; PMID:10843985; http://dx.doi.org/10. 1074/jbc.C000276200 (Pubitemid 30624678)
53. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490:61-70; PMID:23000897; http://dx.doi.org/10. 1038/nature11412
54. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2:401-4; PMID:22588877; http://dx.doi.org/10.1158/2159-8290.CD-12-0095
55. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6:pl1; PMID:23550210; http://dx.doi.org/10.1126/scisignal.2004088
56. Kotian S, Liyanarachchi S, Zelent A, Parvin JD. Histone deacetylases 9 and 10 are required for homologous recombination. J Biol Chem 2011; 286:7722-6; PMID:21247901; http://dx.doi.org/10.1074/jbc. C110.194233